lomustine and plx4032

lomustine has been researched along with plx4032 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hernberg, M; Kohtamäki, L; Koivunen, J; Mäkelä, S; Mattila, KE; Ramadan, S; Skyttä, T; Tiainen, L; Tyynelä-Korhonen, K; Vihinen, P; Vuoristo, MS1

Other Studies

1 other study(ies) available for lomustine and plx4032

ArticleYear
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
    Acta oncologica (Stockholm, Sweden), 2020, Volume: 59, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Female; Follow-Up Studies; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Prognosis; Survival Rate; Temozolomide; Vemurafenib; Vincristine

2020